June 26, 2020 / 12:58 PM / 10 days ago

BRIEF-Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary

June 26 (Reuters) - Helix Biopharma Corp:

* PRESS RELEASE - HELIX BIOPHARMA CORP. TO DIVEST REMAINING OWNERSHIP OF POLISH SUBSIDIARY

* HELIX BIOPHARMA - HAS ENTERED INTO A NON-BINDING TERM SHEET TO DIVEST REMAINING SHARES IT HOLDS IN ITS POLISH SUBSIDIARY HELIX IMMUNO-ONCOLOGY S.A. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below